13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 59 holding rows worth $133,118,577.
- Accession
- 0001420506-25-000519
- Filer
- CIK 2011932
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 59 entries on the cover page, a total value of $133,118,577 stated on the cover page (in dollars after the unit check, H1), rows summing to $133,118,577 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 246,700 | $6,769,448 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 8,247 | $6,366,684 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,561,152 | $5,622,690 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 18,066 | $4,583,525 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 147,800 | $4,515,290 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,083,487 | $4,463,966 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 69,072 | $4,379,165 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 318,900 | $4,215,858 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 218,700 | $4,192,479 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 151,965 | $4,121,291 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 7,427 | $3,876,597 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 119,467 | $3,812,192 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 65,200 | $3,687,712 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 40,500 | $3,617,460 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 22,450 | $3,553,835 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 77,285 | $3,473,961 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 77,439 | $3,346,914 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 40,580 | $3,186,025 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 65,883 | $3,099,136 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 31,800 | $2,773,596 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 29,700 | $2,743,389 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 130,412 | $2,327,202 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 137,716 | $2,306,743 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 81,473 | $2,175,329 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 40,123 | $2,148,185 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 699,698 | $2,148,073 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 61,367 | $2,145,390 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 9,000 | $2,137,320 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 159,552 | $2,005,569 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 68,608 | $1,908,675 | dollars as filed | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 117,500 | $1,855,325 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 10,000 | $1,847,100 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 225,323 | $1,762,026 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 28,178 | $1,560,216 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 2,000,000 | $1,556,395 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 103,504 | $1,363,148 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 283,599 | $1,332,915 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 113,096 | $1,247,449 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 37,600 | $1,223,504 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 26,081 | $1,204,160 | dollars as filed | |
| ALVOTECH | L01800108 | ORDINARY SHARES | 90,100 | $1,192,023 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 353,434 | $1,184,004 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 256,373 | $1,056,257 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 28,159 | $1,051,739 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,097,999 | $993,250 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 389,333 | $965,546 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 144,830 | $742,978 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 1,117,600 | $739,509 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 234,435 | $736,126 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 54,738 | $662,877 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 13,100 | $603,517 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 618,174 | $574,902 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 127,960 | $419,709 | dollars as filed | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 205,956 | $391,316 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 987 | $304,559 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 102,631 | $295,064 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 172,924 | $249,723 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979900 | COM | 600 | $207,000 | dollars as filed | call |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 28,300 | $92,541 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-000519 | this filing | 2025-02-14 | acceptance time not in the bulk data set |